SVP, R&D, CMO · Emergent BioSolutions Inc. · Common Stock
Side
F
Value
$40K
Shares
3,543
Price
$11.41
Executed
Dec 14, 2025
Disclosed
Dec 16, 2025
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Dec 14 executedDec 16, 2025 disclosed
EBS · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Tax withholding — administrative, little informational value
Relative size+1 / 25
$40K reported value · 4.2% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Lowry Simon C filed this Form 4 reporting a tax withholding of EBS on Dec 14, 2025. It became public on Dec 16, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
SVP, R&D, CMO
Lowry Simon Ccik:0002044279
Issuer
Emergent BioSolutions Inc.cik:0001367644
Revision history · 0
No field has changed since this record was first ingested.
